Redbiotec AG:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Redbiotec AG - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10641
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スイス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Redbiotec AG (Redbiotec) is a biopharmaceutical company that develops prophylactic vaccines, which target various virus associated diseases. The company produces multi component virus like particles and other protein assemblies through its rePAX coexpression technology. It is developing products in the areas of CMV, HPV and influenza. Redbiotec also develops herpes vaccines. The company’s products find applications in the areas of cervical cancer induced by human papilloma virus; and influenza. It also provides customized solutions in biologics. The company operates through various pharmaceutical and biotech companies and universities. Redbiotec is headquartered in Schlieren, Switzerland.

Redbiotec AG – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Redbiotec AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Redbiotec AG, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Redbiotec AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Redbiotec AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Redbiotec AG, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Redbiotec AG, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Redbiotec Enters into Agreement with GE Healthcare Life Sciences for Cytomegalovirus Vaccine Development 10
Redbiotec Forms Joint Venture With TeselaGen For Herpesvirus Vaccine Development 11
Redbiotec Enters Into Co-Development Agreement With Roche Diagnostics 12
Redbiotec Extends Drug Discovery Agreement With Merck 13
Redbiotec Enters Into Agreement To Develop Novel Therapeutic Antibodies 14
Redbiotec AG – Key Competitors 15
Redbiotec AG – Key Employees 16
Redbiotec AG – Locations And Subsidiaries 17
Head Office 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
Redbiotec AG, Pharmaceuticals & Healthcare, Key Facts 2
Redbiotec AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Redbiotec AG, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Redbiotec AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Redbiotec AG, Deals By Therapy Area, 2012 to YTD 2018 8
Redbiotec AG, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Redbiotec Enters into Agreement with GE Healthcare Life Sciences for Cytomegalovirus Vaccine Development 10
Redbiotec Forms Joint Venture With TeselaGen For Herpesvirus Vaccine Development 11
Redbiotec Enters Into Co-Development Agreement With Roche Diagnostics 12
Redbiotec Extends Drug Discovery Agreement With Merck 13
Redbiotec Enters Into Agreement To Develop Novel Therapeutic Antibodies 14
Redbiotec AG, Key Competitors 15
Redbiotec AG, Key Employees 16

List of Figures
Redbiotec AG, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Redbiotec AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Redbiotec AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Redbiotec AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Redbiotec AG, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Redbiotec AG, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Redbiotec AG, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Redbiotec AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Redbiotec AG:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Specsavers Optical Group Ltd:企業の戦略・SWOT・財務分析
    Specsavers Optical Group Ltd - Strategy, SWOT and Corporate Finance Report Summary Specsavers Optical Group Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • PACCAR Inc (PCAR):企業の財務・戦略的SWOT分析
    PACCAR Inc (PCAR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • BBVA Banco Frances S.A.:企業の戦略・SWOT・財務分析
    BBVA Banco Frances S.A. - Strategy, SWOT and Corporate Finance Report Summary BBVA Banco Frances S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Quadrise Fuels International Plc (QFI)-石油・ガス分野:企業M&A・提携分析
    Summary Quadrise Fuels International Plc (QFI), formerly Zareba Plc, is an oil-in-water emulsified fuel developer that manufactures and markets MSAR (Multiphase Superfine Atomised Residue), an emulsion fuel as a low cost substitute for conventional heavy fuel oil (HFO) for use in power generation pl …
  • Ansaldo Thomassen BV:企業の戦略的SWOT分析
    Ansaldo Thomassen BV - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • BankNordik P/F:企業の戦略・SWOT・財務分析
    BankNordik P/F - Strategy, SWOT and Corporate Finance Report Summary BankNordik P/F - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • BJ’s Wholesale Club Inc:企業の戦略・SWOT・財務情報
    BJ's Wholesale Club Inc - Strategy, SWOT and Corporate Finance Report Summary BJ's Wholesale Club Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Cintas Corp (CTAS):企業の財務・戦略的SWOT分析
    Cintas Corp (CTAS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Clalit Health Services:企業の戦略的SWOT分析
    Clalit Health Services - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • OCI Co Ltd (010060):電力:M&Aディール及び事業提携情報
    Summary OCI Co Ltd (OCI) is a green energy and chemical company. It manufactures and sells a wide range of inorganic chemicals, coal and petrochemicals, and fine chemicals. The company’s product portfolio includes toluene di-isocyanate (TDI), hydrogen peroxide, carbon black, pitch, sodium percarbona …
  • Victoria PLC (VCP):企業の財務・戦略的SWOT分析
    Victoria PLC (VCP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • CytoBioscience Inc:医療機器:M&Aディール及び事業提携情報
    Summary CytoBioscience Inc (CytoBioscience), formerly Cytocentrics Bioscience GmbH is a biotechnology company that manufactures of medical devices for ion channel research. The company’s products include CytoPatch instrumentations. It provides services such as adult human heart, expression systems, …
  • Butler National Corporation:企業の戦略・SWOT・財務分析
    Butler National Corporation - Strategy, SWOT and Corporate Finance Report Summary Butler National Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • China National Chemical Corp:企業の戦略的SWOT分析
    China National Chemical Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • S.C. Termoelectrica SA:企業の戦略的SWOT分析
    S.C. Termoelectrica SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Centrais Eletricas Brasileiras S.A.:企業の戦略・SWOT・財務情報
    Centrais Eletricas Brasileiras S.A. - Strategy, SWOT and Corporate Finance Report Summary Centrais Eletricas Brasileiras S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • H&R Block, Inc.:戦略・SWOT・企業財務分析
    H&R Block, Inc. - Strategy, SWOT and Corporate Finance Report Summary H&R Block, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Avanir Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Avanir Pharmaceuticals Inc (Avanir) a subsidiary of Otsuka America, Inc. is a biopharmaceutical company which focuses on developing medicines for patients suffering from central nervous system disorders. The company’s lead products include NUEDEXTA (AVP-923), a first-in-class dual N-methyl-D …
  • Boralex Inc (BLX)-エネルギー分野:企業M&A・提携分析
    Summary Boralex Inc. (Boralex) is a renewable energy company that develops, constructs, and operates power plants. It produces electricity from wind, solar, hydro, natural gas, and wood residue sources; and sells that energy through long-term contracts. Boralex sources wood residues such as bark, wo …
  • Bawag Psk
    Bawag Psk - Strategy, SWOT and Corporate Finance Report Summary Bawag Psk - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆